Literature DB >> 9417202

Echocardiographic and cardiac Doppler assessment of mice.

C Pollick1, S L Hale, R A Kloner.   

Abstract

Recent studies have suggested that intermediate-frequency M-Mode transthoracic echocardiographic imaging is a promising method for evaluating the left ventricle in transgenic mice. However, there is a paucity of data regarding two-dimensional (2-D) echocardiography and cardiac Doppler echocardiography in this model. Therefore we studied 15 mice (body weights 38 to 65 gm) with an ultrasound system equipped with a 9 MHz transducer. M-mode, 2-D, pulsed, and color-flow Doppler studies were performed. Mean +/- SD for septal, posterior wall, and left ventricular cavity dimensions at end diastole were the following: M-mode: 1.1 +/- 0.2, 1.0 +/- 0.2, and 3.7 +/- 0.7 mm; 2-D: 1.0 +/- 0.2, 1.1 +/- 0.3, and 3.0 +/- 0.6mm. Left ventricular fractional shortening was assessed from the M-mode echocardiogram: mean 53.7% +/- 10.7% (range 42% to 77%). 2-D assessment of left ventricular mass correlated better with left ventricular mass identified at necropsy than left ventricular mass identified by M-mode echocardiography (r = 0.70; p = 0.007 versus r = 0.07; p not significant). 2-D visualization of left ventricle, proximal aorta, and aortic and mitral valves was excellent and was obtained mainly from a "parasternal" window. Apical views were more difficult to obtain. Mean +/- SD for aortic peak and mean velocities and velocity-time integral were 0.53 +/- 0.13, 0.32 +/- 0.08, and 0.025 +/- 0.008 m/sec. Estimated stroke volume was 0.0506 +/- 0.018 ml/beat. Cardiac output was 12.64 +/- 7.87 ml/min. Mean +/- SD for mitral peak E, peak A, and E/A ratio were 0.45 +/- 0.09 m/sec, 0.19 +/- 0.06 m/sec, and 2.4 +/- 0.66 m/sec, respectively. In all mice the E/A ratio was greater than 1 (range 1.76 to 3.6). Color-flowing imaging clearly displayed normal mitral inflow and left ventricular outflow. In one mouse, aortic regurgitation was recorded by pulsed Doppler echocardiography. Echocardiographic, pulsed, and color-flow Doppler assessment of mice is feasible. In this study left ventricular mass was assessed better by 2-D measurement of left ventricular dimensions. Assessment of left ventricular performance is feasible. Color Doppler-guided evaluation of aortic flow and aortic root measurement permits assessment of stroke volume and cardiac output.

Entities:  

Mesh:

Year:  1995        PMID: 9417202     DOI: 10.1016/s0894-7317(05)80373-6

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  24 in total

1.  Controlled dual delivery of fibroblast growth factor-2 and Interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair.

Authors:  William C W Chen; Brandon G Lee; Dae Woo Park; Kyobum Kim; Hunghao Chu; Kang Kim; Johnny Huard; Yadong Wang
Journal:  Biomaterials       Date:  2015-09-02       Impact factor: 12.479

2.  Decellularized neonatal cardiac extracellular matrix prevents widespread ventricular remodeling in adult mammals after myocardial infarction.

Authors:  Zhouguang Wang; Daniel W Long; Yan Huang; William C W Chen; Kang Kim; Yadong Wang
Journal:  Acta Biomater       Date:  2019-01-30       Impact factor: 8.947

3.  Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice.

Authors:  Yukitaka Shizukuda; Satoaki Matoba; Omar Y Mian; Tammy Nguyen; Paul M Hwang
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

4.  Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes.

Authors:  Ahmed T Beggah; Brigitte Escoubet; Stefania Puttini; Stephane Cailmail; Vanessa Delage; Antoine Ouvrard-Pascaud; Brigitte Bocchi; Michel Peuchmaur; Claude Delcayre; Nicolette Farman; Frederic Jaisser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

5.  Systematic characterization of myocardial inflammation, repair, and remodeling in a mouse model of reperfused myocardial infarction.

Authors:  Panagiota Christia; Marcin Bujak; Carlos Gonzalez-Quesada; Wei Chen; Marcin Dobaczewski; Anilkumar Reddy; Nikolaos G Frangogiannis
Journal:  J Histochem Cytochem       Date:  2013-05-28       Impact factor: 2.479

6.  Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age.

Authors:  Gautam Sikka; Karen L Miller; Jochen Steppan; Deepesh Pandey; Sung M Jung; Charles D Fraser; Carla Ellis; Daniel Ross; Koenraad Vandegaer; Djahida Bedja; Kathleen Gabrielson; Jeremy D Walston; Dan E Berkowitz; Lili A Barouch
Journal:  Exp Gerontol       Date:  2012-11-13       Impact factor: 4.032

7.  Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene.

Authors:  D Fatkin; M E Christe; O Aristizabal; B K McConnell; S Srinivasan; F J Schoen; C E Seidman; D H Turnbull; J G Seidman
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

8.  Infection of cardiomyocytes and induction of left ventricle dysfunction by neurovirulent polytropic murine retrovirus.

Authors:  Mohammed Khaleduzzaman; Joseph Francis; Meryll E Corbin; Elizabeth McIlwain; Marc Boudreaux; Min Du; Tim W Morgan; Karin E Peterson
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

9.  Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart.

Authors:  R C Fentzke; C E Korcarz; R M Lang; H Lin; J M Leiden
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

10.  Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers.

Authors:  Natee Jearawiriyapaisarn; Hong M Moulton; Peter Sazani; Ryszard Kole; Monte S Willis
Journal:  Cardiovasc Res       Date:  2009-10-08       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.